A detailed history of Pathstone Holdings, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 31,779 shares of PACB stock, worth $57,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,779
Previous 10,219 210.98%
Holding current value
$57,202
Previous $14,000 285.71%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$1.2 - $2.17 $25,872 - $46,785
21,560 Added 210.98%
31,779 $54,000
Q2 2024

Aug 14, 2024

SELL
$1.36 - $3.65 $7,757 - $20,819
-5,704 Reduced 35.82%
10,219 $14,000
Q1 2024

May 13, 2024

BUY
$3.52 - $9.59 $2,566 - $6,991
729 Added 4.8%
15,923 $59,000
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $90,708 - $157,409
15,194 New
15,194 $149,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $405M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.